Health secretary Robert F. Kennedy Jr. this week is sowing doubt about the safety and efficacy of some vaccines — beyond the ...

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

A FDA generic drug office was eliminated — and the implications will be felt not only by drugmakers, but consumers ...

A group of academics is arguing that countries seeking access to a groundbreaking HIV prevention drug from Gilead Sciences ...

A week after President Trump instituted broad tariffs on imports during his “Liberation Day,” he abruptly announced yesterday ...

“I am Medicaid, don’t cut me! I am Medicaid, don’t cut me!” The chants echoed across the grass in front of the Capitol ...

Biotech stocks and the broader markets snapped higher Wednesday after President Trump announced a 90-day pause on reciprocal tariffs for all countries except China, backing down from a trade policy ...

STATUS List features 50 influential people shaping the future of biotech, medicine, health care, policy, and health tech.

This isn’t just an animal health crisis — it’s a risk to public health. When animals consume foods containing live virus, ...

The National Cancer Institute’s Investigational New Drug program facilitates collaboration, not collusion, with industry for ...

A small office that produced data on alcohol-related deaths and harms, and worked on policies to reduce them, has been ...

Robert F. Kennedy Jr. has shown "complete disregard for science” and should resign, says Georges Benjamin of the American ...